New injection shows promise for sinus sufferers

NCT ID NCT06451640

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a new medicine called TQC2731, given as an injection, to see if it is safe and works well for people with long-term sinus inflammation and nasal polyps (growths in the nose). The trial involved 59 adults who had already completed a previous study of the same drug. The main goal was to check for side effects and measure changes in nasal polyp size. This treatment aims to control the disease, not cure it, and may require ongoing use.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC RHINOSINUSITIS WITH NASAL POLYPS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Affiliated Hospital of Zunyi Medical University

    Zunyi, Guizhou, 563000, China

  • Affiliated Zhongshan Hospital Of Dalian university

    Dalian, Liaoning, 116001, China

  • Cangzhou Central Hospital

    Cangzhou, Hebei, 061017, China

  • ChengDu Second People's Hospital

    Chengdu, Sichuan, 610021, China

  • Eye&Ent Hospital of Fudan University

    Shanghai, Shanghai Municipality, 20031, China

  • Hospital of Chengdu University of TCM

    Chengdu, Sichuan, 610072, China

  • Jingzhou Central Hospital

    Jingzhou, Hubei, 434020, China

  • The Affiliated Hospital of Xuzhou Medical University

    Xuzhou, Jiangsu, 221000, China

  • The Afiliated Hospital Of QINGDAO University

    Qingdao, Shandong, 266071, China

  • The First Affiliated Hospital of Nanchang University

    Nanchang, Jiangxi, 330000, China

  • The First Affiliated Hospital of Suzhou University

    Suzhou, Jiangsu, 215000, China

  • The First Affiliated Hospital of Xi'an Jiao Tong University

    Xi'an, Shaanxi, 710000, China

  • The First Affiliated Hospital of Xinjiang Medical University

    Ürümqi, Xinjiang, 830000, China

  • The Third Xiangya Hospital of Central South University

    Changsha, Hunan, 410013, China

  • Tianjin People's Hospital

    Tianjin, Tianjin Municipality, 300122, China

  • West China Hospital

    Chengdu, Sichuan, 610041, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.